Chronic Limb‐Threatening Ischemia Shows No Adaptability of Mitochondrial Function After Revascularisation
Journal of Cellular and Molecular Medicine · 2026-10 · 30 (20)
DOI: 10.1111/jcmm.71383 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 16.10.2026. Verfasst von Fiona Speichinger und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General and Visceral Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Mitochondria, Chronic Limb-Threatening Ischemia, Mitochondria, Muscle, Ischemia. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Peripheral arterial disease (PAD) impairs limb perfusion, leading to myopathy characterised by altered mitochondrial content and respiration. Because ischemic muscle appears to adapt differently across PAD stages, we examined stage‐specific skeletal‐muscle mitochondrial function before and after successful revascularisation. Muscle biopsies of gastrocnemius and vastus lateralis muscle were obtained from 32 patients—21 with intermittent claudication (IC) and 11 with chronic limb‐threatening ischemia (CLTI)—before and 6 weeks after successful revascularisation. Mitochondrial respiration was assessed by high resolution respirometry (HRR). HRR results were normalised to citrate synthase activity (CSA) as a marker of mitochondrial content. Inter‐individual variation was expressed as the gastrocnemius‐to‐vastus respiration ratio (‘GV ratio’). In the IC group, CSA‐normalised mitochondrial respiration of gastrocnemius muscle was significantly reduced after revascularisation, paralleled by a significant decline in the GV ratio. In contrast, CLTI patients showed no significant pre‐ to postoperative change in CSA‐normalised respiration or GV ratio, but mitochondrial content significantly improved by revascularisation. Mitochondrial respiration 6 weeks after successful revascularisation adapts only modestly in milder PAD stages such as IC, while more advanced stages (CLTI) display no functional adaptations. These findings suggest that mitochondrial adaptive capacity is stage‐dependent and may require targeted therapeutic strategies beyond revascularisation alone, especially in CLTI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General and Visceral Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Department of Vascular Surgery, Charité Universitätsmedizin Berlin, Berlin, Germany.
- Department of Vascular Surgery, Konventhospital Barmherzige Brueder Linz, Linz, Austria.
- German Aerospace Center, Institute of Aerospace Medicine, Cologne, Germany.
- Medical Faculty, University of Cologne, Cologne, Germany.
- Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
ORCID-Profile: Fiona Speichinger, Alexandra Gratl, Marco Arndt, Nina A Hering, Dominik Pesta, Christian Schineis, Jan Paul Frese
Zitieren
APA
Speichinger, F., Gratl, A., Raude, B., Arndt, M., Hering, N. A., Greiner, A., Pesta, D., Schineis, C., & Frese, J. P. (2026). Chronic Limb‐Threatening Ischemia Shows No Adaptability of Mitochondrial Function After Revascularisation. Journal of Cellular and Molecular Medicine, 30(20). https://doi.org/10.1111/jcmm.71383
Vancouver
Speichinger F, Gratl A, Raude B, Arndt M, Hering NA, Greiner A, et al. Chronic Limb‐Threatening Ischemia Shows No Adaptability of Mitochondrial Function After Revascularisation. Journal of Cellular and Molecular Medicine. 2026;30(20). doi:10.1111/jcmm.71383
BibTeX
@article{Speichinger2026,
author = {Speichinger, Fiona and Gratl, Alexandra and Raude, Ben and Arndt, Marco and Hering, Nina A and Greiner, Andreas and Pesta, Dominik and Schineis, Christian and Frese, Jan Paul},
title = {Chronic Limb‐Threatening Ischemia Shows No Adaptability of Mitochondrial Function After Revascularisation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {20},
doi = {10.1111/jcmm.71383}
}
EUVIMED